描述

根据 StrategyHelix 的报告, the global high content screening market is set to increase by US$ 839.4 期间百万 2022-2028, 复合年增长率为 9.2% 在预测期内.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for high content screening. The global high content screening market is segmented on the basis of component, 应用, 最终用户, 和地区. On the basis of component, the global high content screening market has been segmented into consumables (reagents and kits), instrument or platform, 服务, software and analytics. The instrument or platform segment held the largest revenue share in 2021. 按申请, the global high content screening market has been segmented into compound profiling, drug discovery, molecular diagnosis, oncology, toxicity studies, 其他的. 在这些当中, the drug discovery segment was accounted for the highest revenue generator in 2021. Based on end user, the global high content screening market is categorized into academic institutions, laboratories and pathology centers, pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology companies segment captured the largest share of the market in 2021. 地理上, the global high content screening market is segmented into Asia Pacific, 欧洲, 北美, 世界其他地区 (排).

The instrument market is further segmented into cytometers, detectors and sensors, imaging devices, liquid handling instruments, plate readers, 和别的. 全球范围, the imaging devices segment made up the largest share of the high content screening market.

The global high content screening market is highly competitive. The prominent players operating in the global high content screening market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corp., GE Healthcare, Merck KGaA, 奥林巴斯公司, PerkinElmer Inc., 赛多利斯公司, Thermo Fisher Scientific Inc., 横河电机株式会社.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the high content screening market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

成分: consumables (reagents and kits), instrument or platform, 服务, software and analytics
应用: compound profiling, drug discovery, molecular diagnosis, oncology, toxicity studies, 其他的
最终用户: academic institutions, laboratories and pathology centers, pharmaceutical and biotechnology companies
地区: 亚太地区, 欧洲, 北美, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global high content screening market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. High content screening market overview
部分 3. 按组件划分的市场细分
– Consumables (reagents and kits)
– Instrument or platform
– 服务
– Software and analytics
部分 4. 按应用划分的市场细分
– Compound profiling
– Drug discovery
– Molecular diagnosis
– Oncology
– Toxicity studies
– 其他的
部分 5. 按最终用户划分的市场细分
– Academic institutions
– Laboratories and pathology centers
– Pharmaceutical and biotechnology companies
部分 6. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)
部分 7. 重点企业
– Agilent Technologies Inc.
– Bio-Rad Laboratories, 公司.
– Danaher Corp.
– GE Healthcare
– Merck KGaA
– 奥林巴斯公司
– PerkinElmer, 公司.
– 赛多利斯公司
– Thermo Fisher Scientific Inc.
– 横河电机株式会社
关于StrategyHelix
免责声明